EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients

Dixie Bakker, Walbert J Bakker, Marcel W Bekkenk, Rosalie M Luiten iD

Cells · 2023

DOI: 10.3390/cells12202441 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Dixie Bakker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amster…. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Organ Transplantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-melanoma skin cancers (NMSCs) occur frequently in the Caucasian population and are considered a burden for health care. Risk factors include ultraviolet (UV) radiation, ethnicity and immunosuppression. The incidence of NMSC is significantly higher in solid organ transplant recipients (SOTRs) than in immunocompetent individuals, due to immunosuppressive medication use by SOTRs. While the immunosuppressive agents, calcineurin inhibitors and purine analogues increase the incidence of NMSC in transplant recipients, mTOR inhibitors do not. This is most likely due to the different immunological pathways that are inhibited by each class of drug. This review will focus on what is currently known about the immune response against cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC), two of the main types of NMSC. Furthermore, we will describe the different classes of immunosuppressants given to SOTRs, which part of the immune system they target and how they can contribute to NMSC development. The risk of developing NMSC in SOTRs is the result of a combination of inhibiting immunological pathways involved in immunosurveillance against NMSC and the direct (pro/anti) tumor effects of immunosuppressants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellOrgan TransplantationHumansTransplant RecipientsImmunosuppressive Agents

Stichwörter der Autor:innen

cancer immunityimmune suppressionnon-melanoma skin cancertransplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam University Medical Centers, VU University of Amsterdam, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Rosalie M Luiten

Zitieren

APA

Bakker, D., Bakker, W. J., Bekkenk, M. W., & Luiten, R. M. (2023). Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients. Cells. https://doi.org/10.3390/cells12202441

Vancouver

Bakker D, Bakker WJ, Bekkenk MW, Luiten RM. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients. Cells. 2023. doi:10.3390/cells12202441

BibTeX
@article{Bakker2023,
  author = {Bakker, Dixie and Bakker, Walbert J and Bekkenk, Marcel W and Luiten, Rosalie M},
  title = {Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12202441}
}
Kostenlos starten →